Gabriela Rios Martini, Philipp Hofmann, Ann-Kristin Kamps, Amos Weichberger, Ekaterina Tikhonova, Aidan Conroy, Xiangyu Pan, Diana Milagros Namuch, Laura Rathjens, Arne Bergfeld, Susanna Nikolaus, Jeanette Riffert, Florian Tran, Konrad Aden, Maria Witte, Clemens Schafmayer, Dora Stölzl, Stephan Weidinger, Markus M Heimesaat, Miriam Cyris, Ann-Kristin Härdter, Christof Dörfer, Robert Zarnowski, David Andes, Sascha Brunke, Bernhard Hube, Alexander Scheffold, Iliyan D Iliev, Stefan Schreiber, Petra Bacher
{"title":"Antigen-restricted Candida albicans Th17 cells link oral-gut immunity and adopt pathogenic features during intestinal inflammation.","authors":"Gabriela Rios Martini, Philipp Hofmann, Ann-Kristin Kamps, Amos Weichberger, Ekaterina Tikhonova, Aidan Conroy, Xiangyu Pan, Diana Milagros Namuch, Laura Rathjens, Arne Bergfeld, Susanna Nikolaus, Jeanette Riffert, Florian Tran, Konrad Aden, Maria Witte, Clemens Schafmayer, Dora Stölzl, Stephan Weidinger, Markus M Heimesaat, Miriam Cyris, Ann-Kristin Härdter, Christof Dörfer, Robert Zarnowski, David Andes, Sascha Brunke, Bernhard Hube, Alexander Scheffold, Iliyan D Iliev, Stefan Schreiber, Petra Bacher","doi":"10.1016/j.immuni.2026.06.013","DOIUrl":null,"url":null,"abstract":"<p><p>The commensal yeast Candida albicans is a major inducer of human mucosal Th17 cells. How C. albicans drives Th17 cell responses at homeostasis, and whether such responses contribute to inflammatory diseases, remains poorly understood. Here, we showed that C. albicans-reactive Th17 cells targeted a limited set of proteins enriched in fungal extracellular vesicles. At homeostasis, these cells predominantly resided in the oral mucosa. However, T cell receptor profiling revealed shared clonotypes across oral and gut tissues, with C. albicans being a major driver of this repertoire overlap. In patients with Crohn's disease, C. albicans-specific Th17 cells with features of oral priming were enriched in intestinal tissues, where they retained their focused antigen specificity but acquired pathogenic Th17 cell traits. Together, our results reveal a stable, antigen-restricted C. albicans Th17 subset that is shared across mucosal sites and undergoes functional adaptation in the inflamed intestine. These cells represent a potential target for immune modulation in Crohn's disease.</p>","PeriodicalId":13269,"journal":{"name":"Immunity","volume":" ","pages":"2545-2561.e10"},"PeriodicalIF":30.6000,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.immuni.2026.06.013","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The commensal yeast Candida albicans is a major inducer of human mucosal Th17 cells. How C. albicans drives Th17 cell responses at homeostasis, and whether such responses contribute to inflammatory diseases, remains poorly understood. Here, we showed that C. albicans-reactive Th17 cells targeted a limited set of proteins enriched in fungal extracellular vesicles. At homeostasis, these cells predominantly resided in the oral mucosa. However, T cell receptor profiling revealed shared clonotypes across oral and gut tissues, with C. albicans being a major driver of this repertoire overlap. In patients with Crohn's disease, C. albicans-specific Th17 cells with features of oral priming were enriched in intestinal tissues, where they retained their focused antigen specificity but acquired pathogenic Th17 cell traits. Together, our results reveal a stable, antigen-restricted C. albicans Th17 subset that is shared across mucosal sites and undergoes functional adaptation in the inflamed intestine. These cells represent a potential target for immune modulation in Crohn's disease.
期刊介绍:
Immunity is a publication that focuses on publishing significant advancements in research related to immunology. We encourage the submission of studies that offer groundbreaking immunological discoveries, whether at the molecular, cellular, or whole organism level. Topics of interest encompass a wide range, such as cancer, infectious diseases, neuroimmunology, autoimmune diseases, allergies, mucosal immunity, metabolic diseases, and homeostasis.